{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:52:41Z","timestamp":1762429961577},"reference-count":21,"publisher":"American Public Health Association","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Public Health"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:p> Twenty-five years after the eradication of smallpox, the ongoing effort to eradicate poliomyelitis has grown into the largest international health initiative ever undertaken. <\/jats:p><jats:p> By 2004, however, the polio eradication effort was threatened by a challenge regularly faced by public health policymakers everywhere\u2014misperception about the benefits and risks of vaccines. The propagation of false rumors about oral poliovirus vaccine safety led to the reinfection of 13 previously polio-free countries and the largest polio epidemic in Africa in recent years. <\/jats:p><jats:p> With deft management of such challenges by local, national, and international health authorities, poliomyelitis, a disease that threatened children everywhere just 2 generations ago, could soon be relegated to history like smallpox before it. <\/jats:p>","DOI":"10.2105\/ajph.2004.055897","type":"journal-article","created":{"date-parts":[[2005,4,26]],"date-time":"2005-04-26T20:33:24Z","timestamp":1114547604000},"page":"773-777","source":"Crossref","is-referenced-by-count":23,"title":["Can We Capitalize on the Virtues of Vaccines? Insights from the Polio Eradication Initiative"],"prefix":"10.2105","volume":"95","author":[{"given":"R. Bruce","family":"Aylward","sequence":"first","affiliation":[{"name":"The authors are with the Polio Eradication Initiative, World Health Organization, Geneva, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Heymann","sequence":"additional","affiliation":[{"name":"The authors are with the Polio Eradication Initiative, World Health Organization, Geneva, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"844","reference":[{"key":"R1","unstructured":"Foege WH. Conference synthesis and vision for the future. Bull World Health Organ. 1998;76(suppl 2):109\u2013112."},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.90.10.1515"},{"key":"R3","unstructured":"Progress towards global eradication of poliomyelitis, 2003 and January\u2013April 2004. Wkly Epidemiol Rec. 2004; 79:229\u2013234."},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199103000-00011"},{"key":"R9","unstructured":"Expanded Programme on Immunization. Update: mass vaccination with oral poliovirus vaccine\u2014Asia and Europe, 1996. Wkly Epidemiol Rec. 1996; 71:329\u2013332."},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.Supplement_1.S10"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.91.1.146"},{"key":"R12","unstructured":"Expanded Programme on Immunization. Progress towards global poliomyelitis eradication, 2001. Wkly Epidemiol Rec. 2002;77;98\u2013107."},{"key":"R13","unstructured":"Department of Vaccines and Biologicals. Expanding contributions of the global laboratory network for poliomyelitis eradication. Wkly Epidemiol Rec. 2002;77:133\u2013137."},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14337-1"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038210"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1126\/science.292.5517.615a"},{"key":"R21","unstructured":"Aylward RB, Nshimirimana D, Rosenbauer O, Gasasira A, Heymann D, Konar\u00e9 A. Polio Eradication\u2014African Union (AU) Flagship Programme Back on Track? MERA: Medical Education Resource in Africa. 2004;13:5\u20136."},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068284"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1126\/science.1072266"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1086\/379791"},{"key":"R25","unstructured":"Centers for Disease Control and Prevention. Recommendations for using smallpox vaccine in a pre-event vaccination program. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep. 2003;52(RR-7):1\u201316."},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071207"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1086\/323897"},{"key":"R28","unstructured":"Aylward RB, Cochi SL. Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission. Bull World Health Organ. 2004;82(1):40\u201346."},{"key":"R29","unstructured":"World Health Organization. Progress in certification of poliomyelitis eradication and in laboratory containment of wild poliovirus. Wkly Epidemiol Rec. 2003;44:410\u2013414."}],"container-title":["American Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ajph.aphapublications.org\/doi\/pdf\/10.2105\/AJPH.2004.055897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T22:30:19Z","timestamp":1652135419000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajph.aphapublications.org\/doi\/full\/10.2105\/AJPH.2004.055897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.2105\/AJPH.2004.055897"],"URL":"https:\/\/doi.org\/10.2105\/ajph.2004.055897","relation":{},"ISSN":["0090-0036","1541-0048"],"issn-type":[{"value":"0090-0036","type":"print"},{"value":"1541-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}